The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have launched a collaborative effort to build a comprehensive single-cell atlas capturing cancer cell plasticity and treatment response. This large-scale dataset, derived from 3D organoid cultures, aims to facilitate AI-driven drug discovery and elucidate mechanisms of tumor adaptation and resistance, ultimately providing new insights to improve oncology therapeutics.